Overview

Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

Status:
Enrolling by invitation
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
Women with androgen excess polycystic ovary syndrome (AE-PCOS) leads to hypertension.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Treatments:
Methyltestosterone
Prolactin Release-Inhibiting Factors
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate